Oral glucose sensing in cephalic phase insulin release
Alexa J Pullicin1, Daniel Wils2, Juyun Lim1
1Department of Food Science and Technology, Oregon State University, Corvallis, OR, USA.
Appetite
|October 3, 2023
Summary
Oral stimulation triggers cephalic phase insulin release (CPIR), crucial for managing blood sugar. This study reveals that both glucose detection and its associated taste are vital for eliciting this response in humans.
Area of Science:
- Endocrinology
- Human Physiology
- Nutritional Science
Background:
- Cephalic phase insulin release (CPIR) is a physiological response to food intake that helps regulate postprandial glucose levels.
- The precise sensory mechanisms, particularly gustatory cues, that trigger CPIR remain incompletely understood.
- Existing research suggests carbohydrates like glucose are key elicitors, but the roles of direct glucose detection versus taste perception are debated.
Purpose of the Study:
- To investigate the specific sensory mechanisms, focusing on oral glucose detection and taste, involved in eliciting CPIR in humans.
- To differentiate the contributions of carbohydrate presence versus taste perception in stimulating CPIR.
- To elucidate the interplay between taste inhibition and carbohydrate digestion in modulating CPIR.
Main Methods:
- A controlled study involving 22 healthy adults.
- Four distinct oral stimulation conditions were employed: glucose alone, glucose with a sweet taste inhibitor (Lactisole), maltodextrin alone, and maltodextrin with Lactisole and an oral digestion inhibitor (acarbose).
- Plasma concentrations of c-peptide, insulin, and glucose were measured before and after stimulation in four separate sessions.
Main Results:
- Glucose administered alone effectively elicited CPIR.
- The presence of Lactisole abolished the CPIR response to glucose.
- Maltodextrin alone stimulated CPIR, but this response was negated when Lactisole and acarbose were co-administered.
- These findings highlight the dual role of glucose detection and taste in CPIR.
Conclusions:
- Glucose is a potent stimulus for CPIR, but its associated taste sensation is also a critical cue for triggering this response.
- Both the direct detection of glucose and the perception of its taste are essential for robust CPIR.
- Understanding these gustatory mechanisms provides insight into metabolic regulation and potential therapeutic targets for glucose control.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Hypoglycemia and Glucagon
287
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
287
Oral Hypoglycemic Agents: Glinides
176
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
176
Hormones Regulating Blood Glucose
3.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K
Glucagon-like Receptor Agonists
348
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
348
Glucose Homeostasis: Regulation of Blood Glucose
1.7K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.7K


